# Narcotrend Versus Bispectral Index Monitoring During Sufentanil-Midazolam Anesthesia for Bronchoscopy

> **NCT03738137** · NA · COMPLETED · sponsor: **Guangzhou Institute of Respiratory Disease** · enrollment: 80 (actual)

## Conditions studied

- Bronchoscopy

## Interventions

- **DEVICE:** Narotrend
- **DEVICE:** BIS
- **DRUG:** Sufentanil
- **DRUG:** Lidocaine
- **DRUG:** Midazolam

## Key facts

- **NCT ID:** NCT03738137
- **Lead sponsor:** Guangzhou Institute of Respiratory Disease
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-08-01
- **Primary completion:** 2019-01-15
- **Final completion:** 2019-01-30
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2019-04-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03738137

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03738137, "Narcotrend Versus Bispectral Index Monitoring During Sufentanil-Midazolam Anesthesia for Bronchoscopy". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT03738137. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*